| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy. | Clin Cancer Res | 2013 | 1.07 |
| 2 | Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors. | Int J Cancer | 2012 | 1.01 |
| 3 | MRP3: a molecular target for human glioblastoma multiforme immunotherapy. | BMC Cancer | 2010 | 0.96 |